Researchers from Australia’s Monash University have found a potential new treatment for a common form of “dementia” that affects patients under the age of 60.
According to the scientific website Sci Tech Daily, sodium selenite appeared to stabilize behavioral problems and slow brain shrinkage during Phase I trials, providing hope for patients with behavioral variable frontotemporal dementia.
It is the second most common type of dementia in people under the age of 60.
This is the second clinical trial to show that the drug, sodium selenate, may slow the cognitive decline and neurodegenerative damage that is a hallmark of many types of dementia, including Alzheimer’s disease.
The disease studied can progress rapidly and can occur in people under the age of 35.
It is characterized by behavioral disturbances and personality changes and can be very upsetting and distressing for both patients and their families.
Currently, there are no cures for the disease, and it is fatal very quickly, up to 5-7 years from diagnosis.
The research group is now conducting a larger study in several hospitals across Australia and New Zealand to further test whether the drug is beneficial for patients with the disease.
2023-05-15 03:33:34
#hope #dementia #patients. #Australian #study #discovers #potential #drug
